Your clinician chooses the medication and dose. Medication is billed through your insurance or the pharmacy, separately from the membership.
MEDICATIONBRANDFORMATAPPROVAL
SemaglutideWegovy®Weekly injectionFDA-approved for chronic weight management
TirzepatideZepbound®Weekly injectionFDA-approved for chronic weight management
01Who qualifiesAdults with a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure or type 2 diabetes.
02Who should not use itPeople with a personal or family history of medullary thyroid cancer or MEN2, a history of pancreatitis, or who are pregnant or planning pregnancy.
03What to expectNausea and reduced appetite are common early on. Doses rise gradually, and your clinician adjusts based on how you feel.
THINKRClinician-led weight care and hormone therapy for professionals.support@thinkr.health · (000) 000-0000 Mon–Fri, 8am–8pm ET
HIPAA-COMPLIANTU.S.-LICENSED CLINICIANSLICENSED U.S. PHARMACIESLEGITSCRIPT SEAL · ADD AFTER CERTIFICATION
Prescription treatments are available only after evaluation by a licensed clinician and are not appropriate for everyone. Medications are dispensed by licensed U.S. pharmacies. Compounded medications, including some hormone preparations, are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. Testosterone is a Schedule III controlled substance and is not FDA-approved for use in women. Wegovy® and Zepbound® are registered trademarks of their respective owners; THINKR is not affiliated with their manufacturers. In an emergency, call 911.